Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: A report from the Children’s Oncology Group

PURPOSE: Determine the efficacy and toxicity of higher dose versus standard dose intravenous methotrexate and pulses of high dose cytosine arabinoside with asparaginase versus standard dose cytosine arabinoside and teniposide during intensified continuation therapy for higher risk pediatric B-precur...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tower, Richard L., Jones, Tamekia L., Camitta, Bruce M., Asselin, Barbara L., Bell, Beverly A., Chauvenet, Allen, Devidas, Meenakshi, Halperin, Edward C., Pullen, Jeanette, Shuster, Jonathan J., Winick, Naomi, Kurtzberg, Joanne
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120865/
https://ncbi.nlm.nih.gov/pubmed/24608079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000000131
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars